1. CONCORD DRUGS LIMITED
stock logo

CONCORD DRUGS LIMITED Share Price

CONCORD

₹39.00+₹1.19 (3.15%) TodayLast updated on 17 May, 2024 | 03:29 PM IST
₹37.40₹40.00
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹38 Cr

Open

₹39.00

Close

₹37.81

Circuit range

₹41.59 - ₹34.03

Day range

₹37.40 - ₹40.00

Year range

₹25.56 - ₹61.50

Volume

30,166

Avg. traded

₹38.48

Revenue (12m)

₹42 Cr

CONCORD DRUGS LIMITEDConcord Drugs Limited is an India-based pharmaceutical company. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company offers finished pharmaceutical formulations, such as injectables (small volume parenteral, dry powders), tissue bio-adhesive, tablets, capsules, liquid orals (syrup and suspension) and dry syrups (powder). The Company also provides ready-to-fill pellets and multiple unit pellet system (MUPS). Its injectables include Amikacin Injection, Aceclofenac Injection, Artemether Injection, Adenosine Injection, and others. Iso Amyl 2-Cyano Acrylate is a tissue bio-adhesive. Its pellets are categorized as gastrointestinal drug pellets, cardiovascular drug pellets, respiratory drug pellets, anti-obesity drug pellets, anti-depressant drug pellets, central nervous system drug pellets, urological drug pellets, anti-microbial, anti-infective and adjuvant drugs pellets, taste mask drug pellets/powder, and others.

CONCORD DRUGS LIMITED Key indicators

arrow

52 week high

₹61.50

52 week low

₹25.56

P/E ratio

36.43

P/B ratio

1.04

ROE

2.99%

ROCE

5.97%

Dividend yield

--

Debt/Equity ratio

0.5

EPS

0.96

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

8.48%

Net profit margin

1.73%

ROE

2.99%

ROA

1.57%

ROCE

5.97%

Learn more

CONCORD DRUGS LIMITED Shareholder returns

arrow

1 day

+3.45%

1 week

+5.59%

1 month

+3.25%

3 months

-6.48%

1 year

+25.03%

3 years

+3.17%

5 years

+64.03%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

CONCORD DRUGS LIMITED Share Price history

arrow
DayOpenCloseDay’s change

Shareholding info

arrow

Promoters (55.41%)

Mutual Funds (0%)

Retail and other (44.59%)

Foreign institutions-FII (0%)

Other domestic institutions (0%)

Promoters

Learn more

Events

Empty state

No data available at the moment

Frequently asked questions